Bison Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bison Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-254	Closed	-$30K	–	276
2022 Q2	$30K	Sell	254 -40	-14%	-$4.75K	0.02%	253
2022 Q1	$38K	Sell	294 -355	-55%	-$46.2K	0.02%	281
2021 Q4	$99K	Sell	649 -89	-12%	-$13.8K	0.06%	215
2021 Q3	$119K	Buy	738 +95	+15%	+$16K	0.05%	269
2021 Q2	$105K	Hold	643	–	–	0.05%	276
2021 Q1	$97K	Sell	643 -5	-0.8%	-$794	0.04%	280
2020 Q4	$98K	Buy	648 +25	+4%	+$3.57K	0.05%	263
2020 Q3	$84K	Buy	623 +514	+472%	+$69.7K	0.05%	229
2020 Q2	$15K	Buy	+109	New	+$13.9K	0.01%	297
2015 Q3	–	Sell	-9,918	Closed	-$1.22M	–	240
2015 Q2	$1.22M	Buy	9,918 +783	+9%	+$93.7K	0.71%	31
2015 Q1	$1.05M	Buy	+9,135	New	+$1.01M	0.64%	37

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Bison Wealth's IBB Position: Q3 2022 in Review

Bison Wealth sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 254 shares — an estimated $30K sold.

Bison Wealth first reported a position in IBB in Q1 2015 and held it in 11 quarters. The position peaked at $1.22M in Q2 2015. 830 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Bison Wealth reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
Bison Wealth sold 254 iShares Biotechnology ETF shares in Q3 2022, an estimated $30K.
Bison Wealth first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 11 quarters.
Bison Wealth's iShares Biotechnology ETF position peaked at $1.22M in Q2 2015.
830 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Bison Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.